Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tripterygium glycosides versus acitretin for moderate to severe psoriasis vulgaris
ChiCTR-TRC-12003514Phase 4Recruiting
- Sponsor
- Institute of Dermatology, Chinese Academy of Medical Sciences
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in plaque psoriasis comparing Tripterygium glycosides treatment group with Acitretin treatment group (2 arms). Primary endpoint: PASI75. Started Jan 2011; status: recruiting.
02
Drugs
tripterygium wilfordii polyglycosidesacitretin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on ChiCTR-TRC-12003514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12003514.